• English
• Español
• Français
• Deutsch
• 中文

• Store Login
• Cart
• Support

• About USP
• USP–NF
  • Notices
  • Compendial Tools
  • Sample monograph
  • Publication and comment schedule
  • Revisions and Commentary
  • Development process
  • Pharmacopeial Forum
  • Submit monographs and revisions
  • Pharmacopeial Harmonization
  • Frequently asked questions
• Food Chemicals Codex
• Pending & Non-U.S. Standards
• Reference Standards
• USP Verified
• Pharmacopeial Education
• Healthcare Quality and Information (HQI)
• USP in Developing Countries
• Meetings
• Products

USP–NF Notices

• Inorganic Impurities (Heavy Metals) Stimuli Article  (70KB) (04/23/08)
• Correction to Pharmacopeial Forum 34(2) (03/07/08)

Revision Bulletins

• USP Postpones the Official Date of the Glycerin Monograph: Revisions and Clarifications to be Made (05/09/08)
• General Chapter <2040> Disintegration and Dissolution of Dietary Supplements (05/09/08)
• Fosinopril Sodium and Hydrochlorothiazide Tablets-Revision to Related Compounds Test (03/14/08)
• Acetazolamide Oral Suspension Monograph (02/06/08)
• General Chapter <797> Pharmaceutical Compounding – Sterile Preparations Revised and Finalized (12/03/07)
• Lidocaine and Prilocaine Cream–Revision to Related Compounds Test (11/30/07)
• General Chapter <671> Containers – Performance Testing (12/01/07)
• General Chapter <467> Organic Volatile Impurities/Residual Solvents—Implementation Date Delayed to July 2008 (06/15/07)
• Revision Bulletin: General Chapter <788> Particulate Matter in Injections (04/04/07)

Interim Revision Announcements

• USP Issues Immediate Interim Revision announcement for General Chapter Residual Solvents / Organic Volatile Impurities (03/30/07)
• General Chapter <788> Particulate Matter in Injections (HARMONIZATION) (03/30/07)
• Microbiology Limits Test Chapters (HARMONIZATION) (11/14/06, revised on 12/22/06)
• Extractable Volume (HARMONIZATION) (11/14/06)
• Notice of Revision to General Chapter Heavy Metals <231> Method II (06/14/05)

Postponements

• USP Postpones the Official Date of the Glycerin Monograph: Revisions and Clarifications to be Made (05/09/08)
• Calcium Silicate Monograph (02/06/08)
• USP Issues Postponement for Norgestimate and Ethinyl Estradiol Tablets Monograph Effective August 1, 2007 (08/01/07)
• New monographs for which Reference Standards are not yet available (08/31/07)
• Residual solvents: General Notices and General Chapter <467> (07/12/06)
• Revision Bulletin: Alendronic Acid Tablets (06/14/06)
• Sodium Chloride (02/20/06)
• General Chapter <621> Chromatography - System Suitability (02/20/06)
• Helium, Nitrous Oxide, Nitrogen, and Nitrogen 97 Percent Monographs (01/18/06)
• Fexofenadine Hydrochloride and Fexofenadine Hydrochloride Capsules (04/06/05)

Intent to Revise

• <711> Dissolution: Notice of Intent to Revise (03/11/08)
• Tazobactam: Intent to Revise (02/29/08)
• Alendronate Sodium Tablets (02/01/08)
• Intent to Revise General Chapter <671> Containers–Performance Testing (12/01/07)
• Sodium Fluoride and Acidulated Phosphate Topical Solution (03/07/07)

Explanatory Notes and Announcements

• General Notices proposed revisions available for comment (12/21/07)
• General Chapter <643> Total Organic Carbon Comment Period Extension (10/17/07)
• USP Statement on Prednisone Tablets: Notice of Change in Performance (10/10/07)
• Updated range for USP Prednisone Tablets Reference Standard  (123KB) (07/16/07)
• Delayed Implementation for General Chapter <467> Residual Solvents (06/15/07)
• Explanatory note regarding USP–NF General Chapter <467> Residual Solvents / Organic Volatile Impurities (06/15/07)
• Explanatory Note regarding Revisions to General Chapter <1121> (06/04/07)
• Explanatory note regarding USP–NF General Chapter <905> Uniformity of Dosage Units (04/20/07)
• USP Statement <729> Globule Size Distribution in Lipid Injection Emulsions (02/15/07)
• USP updates guidelines for monograph submissions (01/19/07)
• The USP Performance Test and the Dissolution Procedure Statement (10/24/06)
• Recent Modifications to the USP Standards-Setting Process (07/17/06)
• Implementation Period for Upcoming Official Revisions to the USP–NF Extended (05/03/06)
• Coordination of PF Submissions and New USP Reference Standards (04/26/06)
• Coordination of Official New Monographs, Revisions, and USP Reference Standards (03/17/06)
• USP Releases Improved Packaging for Salicylic Acid Calibrator Tablets (10/19/05)

Errata

• Errata to <467> Organic Volatile Impurities Section in USP Monographs (10/15/07)
• Erratum to <788> Particulate Matter in Injections and the USP Particle Count Reference Standard (08/01/07)
• Notice of Correction to Ranitidine Injection (03/16/07)